Trial
NCT03003390
Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Yale University
Collaborators
St. Louis Children's Hospital; Dell Children's Medical Center of Central Texas; Children's Hospital and Health System Foundation, Wisconsin; Weill Medical College of Cornell University; Maria Fareri Children's Hospital; University of Rochester; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition
Deep Venous Thrombosis
Intervention
Enoxaparin
Why stopped
Met protocol defined stopping rule for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-13